1.Application of ENCOR vacuum -assisted breast minimally invasive revolving system in the diagnosis and treatment of breast tumors
Junbin GUO ; Chunchan ZHAO ; Xiaojie WANG ; Lixia WANG ; Shanshan WANG ; Xiaomin LI
Chinese Journal of Primary Medicine and Pharmacy 2019;26(2):198-201
Objective To study the application effect of ENCOR vacuum-assisted breast minimally invasive polypectomy system in the diagnosis and treatment of breast tumors. Methods Totally 86 breast cancer patients treated in the General Hospital of Yangmei Group from January 2017 to October 2017 were randomly divided into study group and control group,with 43 cases in each group. The study group was treated with ENCOR vacuum-assisted minimally invasive rotational atherectomy system,while the control group was treated by traditional breast excision. The operative conditions, postoperative complications and postoperative recurrence were observed and compared between the two groups. Results The intraoperative bleeding volume,operation time,scar length and postoperative recovery time in the study group were (5.1 ±1.2)mL,(15.9 ±3.5)min,(0.3 ±0.1)cm,(2.7 ±0.4)d,respectively, which in the control group were (12.7 ±2.3)mL,(26.8 ±4.6)min,(3.2 ±1.1)cm and (5.1 ±0.8)d,respectively, the differences between the two groups were statistically significant ( t=15. 579,14. 297,14. 108,13. 597,all P<0. 05). The total incidence rate of postoperative complications in the study group was 11. 63%,which was significantly lower than 30. 23% in the control group (χ2 =5. 187,P<0. 05). During the follow-up of 12 months,in the study group,2 patients (4. 65%) had residual tumor,1 patient (2. 33%) developed recurrence; in the control group, 3 patients (6. 98%) had residual tumor,2 patients (4. 65%) developed recurrence. There was no statistically significant difference between the two groups (χ2 =1. 013,P >0. 05). Conclusion ENCOR vacuum - assisted breast minimally invasive revolving system in the treatment of breast tiny tumors has advantages of less trauma and pain,rapid recovery,etc,it is safe and effective.
2.The evaluation of health economics on the clinical pathway to infantile rotavirus enteritis
Xuguang ZHANG ; Qiang WANG ; Hong SU ; Shuhua HU ; Renhai ZHAO ; Li ZHANG ; Chunchan ZHU ; Shiyang LU ; Lili XU
Chinese Journal of Primary Medicine and Pharmacy 2012;19(19):2913-2914
Objective To explore the influence of the clinical pathway to control on hospital stay and medical expenses of pediatric rotavirus enteritis.Methods 245 infants with IRE were randomly assigned into two groups,109 in research group,136 in control group.All were treated with conventional therapy,for research group with clinical pathway.136 patients with previous medical routine therapy patients in the control group were compared.Compared two sets of average day in hospital,cure rate and cost,expenses for medicine and checking expenses proportion.Results The results shwed that the observation group of children's average hospital stay was lower than the control group,the cure rate higher than that in the control group,each time of total cost,expenses for medicine,each day medicine reducing( P < 0.05 ).Checking expenses proportion was increased ( P < 0.05),as to therapeutic effect,there was significant difference between two groups( P < 0.05 ).Both expenses of drug ratio and ratio of the average daily expenses of drug are reduced.Conclusion Clinical pathway is applied in pediatric rotavirus enteritis can improve recovery rate,reduce hospitalization time and lower hospitalization fees and expenses,charges,medicine and inspection charge proportion.And can improve health education effect and patient satisfaction.